Atherosclerotic cardiovascular (CV) disease (ASCVD) incidence and mortality rates are
declining in many countries in Europe, but it is still a major cause of morbidity and mortality …

Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial
infarction, stroke and peripheral arterial disease continue to be major causes of premature …

Recent advances in human genetics, together with a large body of epidemiologic,
preclinical, and clinical trial results, provide strong support for a causal association between …

The American College of Cardiology (ACC) has a long history of developing documents (eg,
decision pathways, health policy statements, appropriate use criteria) to provide members …

Члены Комитета экспертов подтвердили отсутствие финансовой поддержки/конфликта
интересов. В случае сообщения о наличии конфликта интересов, член (ы) Комитета …

Aims The atherogenic potential of cholesterol in triglyceride-rich lipoproteins, also called
remnant cholesterol, is being increasingly acknowledged. Elevated remnant cholesterol is …

Aims Cholesterol carried in triglyceride-rich lipoproteins, also called remnant cholesterol, is
being increasingly acknowledged as an important causal risk factor for atherosclerosis …

Moreover, over the last few years the approach to treatment of patients with a high
cardiovascular risk has totally changed from treatment aimed at a specific risk factor (ie …

Aims Clinical trials have demonstrated that a reduction in low-density lipoprotein cholesterol
(LDL-C) reduces cardiovascular (CV) events. This has, however, not yet been shown in a …

Objective This guideline will provide the practicing endocrinologist with an approach to the
assessment and treatment of dyslipidemia in patients with endocrine diseases, with the …